Sarah joins CHASE as Senior Consultant in the Executive Recruitment team with over 20 years’ experience in healthcare/pharmaceutical sales and marketing recruitment in the UK and Australia.
Sarah started her career as a Medical Representative in the UK before transitioning into pharmaceutical sales recruitment. She has spent the last 10 years working in executive sales and marketing recruitment in Australia for roles in multiple sectors including: technology, professional services, mining and healthcare.
She brings a deep knowledge and understanding of how to identify the best talent available across markets through multiple channels, delivering the best possible outcomes for clients and candidates.
Danny Walsh, Recruitment Director at CHASE said:
“We’re delighted that Sarah has joined the Executive Recruitment team at CHASE. Her experience and knowledge within the industry will helps us secure the best senior talent for our clients. Welcome Sarah!"
Explore our latest thinking, event updates and industry insights to stay informed.
From April 2027, NHS Carbon Reduction Plan rules demand full scope 3 emissions data. CHASE assesses what this means for pharma and medtech suppliers.
Yvette Cooper is the UK's new health secretary after a reshuffle that also reshaped the medtech brief. Here's what it means for pharma, medtech and NHS teams.
The UK has real strengths in life sciences, but Streeting’s resignation raises new questions about reform continuity. CHASE examines.
.svg)
